Key facts
- This page summarizes Walter H. Moos's Form 4 filing for RIGEL PHARMACEUTICALS INC (RIGL).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 24 Feb 2026, 16:58.
Walter H. Moos - 20 Feb 2026 Form 4 Insider Report for RIGEL PHARMACEUTICALS INC (RIGL)
- Reporting relationship
- Director
- Issuer ticker
- RIGL
- Reported as of
- 20 Feb 2026
- Net transaction value
- -$49,440
- SEC form
- 4
- Accepted by SEC
- 24 Feb 2026, 16:58:28 UTC
- Prior SEC filing
- 28 May 2025
- Next SEC filing
- 19 May 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Raymond Furey (Attorney-in-Fact)
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Walter H. Moos filed Form 4 for RIGEL PHARMACEUTICALS INC (RIGL) on 24 Feb 2026.
Change
- Previous filing in this sequence was filed on 28 May 2025.
- Current net transaction value: -$49,440.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001190272
Primary reporting owner
MOOS WALTER H
- Relationship
- Director
- Address
- RIGEL PHARMACEUTICALS, INC., 611 GATEWAY BLVD, SUITE 900, SOUTH SAN FRANCISCO
- Signature
- /s/ Raymond Furey (Attorney-in-Fact)
- Signature date
- 24 Feb 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
RIGL
transaction
Common Stock
Options Exercise
- Transaction value
- $96,000
- Shares
- +4,000
- Change %
- +31%
- Price
- $24.00
- Shares after
- 16,722
- Date
- 20 Feb 2026
- Ownership
- Direct
- Footnotes
- F1
RIGL
transaction
Common Stock
Sale
- Transaction value
- $145,440
- Shares
- -4,000
- Change %
- -24%
- Price
- $36.36
- Shares after
- 12,722
- Date
- 20 Feb 2026
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
RIGL
transaction
Derivative
Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -4,000
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 20 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 4,000
- Exercise price
- $24.00
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
These numbers have been adjusted to reflect the one-for-ten reverse stock split effective June 27, 2024.
Footnote F2
The shares vested monthly over twelve (12) months from the grant date of May 11, 2016.